These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32986828)

  • 21. Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial.
    Sparano JA; Wang M; Zhao F; Stearns V; Martino S; Ligibel JA; Perez EA; Saphner T; Wolff AC; Sledge GW; Wood WC; Davidson NE
    J Natl Cancer Inst; 2012 Mar; 104(5):406-14. PubMed ID: 22250182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction in Breast Cancer Death With Adjuvant Chemotherapy Among US Women According to Race, Ethnicity, and the 21-Gene Recurrence Score.
    Huang HC; Calip GS; Weiss J; Simons Y; Gadi VK; Danciu OC; Rauscher GH; Hoskins KF
    J Natl Compr Canc Netw; 2024 Jan; 22(1D):e237077. PubMed ID: 38190799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation: A Post Hoc Analysis of a Randomized Clinical Trial.
    Sadigh G; Gray RJ; Sparano JA; Yanez B; Garcia SF; Timsina LR; Obeng-Gyasi S; Gareen I; Sledge GW; Whelan TJ; Cella D; Wagner LI; Carlos RC
    JAMA Oncol; 2022 Apr; 8(4):579-586. PubMed ID: 35175284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study.
    Schindler EA; Takita C; Collado-Mesa F; Reis IM; Zhao W; Yang GR; Acosta LG; Hu JJ
    BMC Womens Health; 2024 May; 24(1):312. PubMed ID: 38816709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Sudden Cardiac Arrest by Race/Ethnicity Among Residents of Ventura County, California, 2015-2020.
    Reinier K; Sargsyan A; Chugh HS; Nakamura K; Uy-Evanado A; Klebe D; Kaplan R; Hadduck K; Shepherd D; Young C; Salvucci A; Chugh SS
    JAMA Netw Open; 2021 Jul; 4(7):e2118537. PubMed ID: 34323985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer.
    Han Y; Miao ZF; Lian M; Peterson LL; Colditz GA; Liu Y
    Breast Cancer Res Treat; 2020 Dec; 184(3):915-925. PubMed ID: 32929567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage.
    Primm KM; Malabay AJ; Curry T; Chang S
    Cancer Med; 2023 Jul; 12(13):14767-14780. PubMed ID: 37212502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer.
    Tesch ME; Speers C; Diocee RM; Gondara L; Peacock SJ; Nichol A; Lohrisch CA
    Cancer; 2022 Feb; 128(4):665-674. PubMed ID: 34855202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer.
    Poorvu PD; Gelber SI; Rosenberg SM; Ruddy KJ; Tamimi RM; Collins LC; Peppercorn J; Schapira L; Borges VF; Come SE; Warner E; Jakubowski DM; Russell C; Winer EP; Partridge AH
    J Clin Oncol; 2020 Mar; 38(7):725-733. PubMed ID: 31809240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal Birthplace is Associated with Low Birth Weight Within Racial/Ethnic Groups.
    Wartko PD; Wong EY; Enquobahrie DA
    Matern Child Health J; 2017 Jun; 21(6):1358-1366. PubMed ID: 28093687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disadvantages for non-Hispanic whites in gastric carcinoma survival in Florida.
    Liu J; Medina H; Reis IM; Sussman DA; Pinheiro PS
    Cancer Causes Control; 2020 Sep; 31(9):815-826. PubMed ID: 32462560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in breast cancer stage, treatment, and survival by race and ethnicity.
    Li CI; Malone KE; Daling JR
    Arch Intern Med; 2003 Jan; 163(1):49-56. PubMed ID: 12523916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women.
    Hoskins KF; Danciu OC; Ko NY; Calip GS
    JAMA Oncol; 2021 Mar; 7(3):370-378. PubMed ID: 33475714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity.
    Moore J; Wang F; Pal T; Reid S; Cai H; Bailey CE; Zheng W; Lipworth L; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):821-830. PubMed ID: 35064066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss.
    Nguyen LL; Hevelone N; Rogers SO; Bandyk DF; Clowes AW; Moneta GL; Lipsitz S; Conte MS
    Circulation; 2009 Jan; 119(1):123-30. PubMed ID: 19103988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
    Litvak A; Batukbhai B; Russell SD; Tsai HL; Rosner GL; Jeter SC; Armstrong D; Emens LA; Fetting J; Wolff AC; Silhy R; Stearns V; Connolly RM
    Cancer; 2018 May; 124(9):1904-1911. PubMed ID: 29381193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race and ethnicity are associated with delays in breast cancer treatment (2003-2006).
    Fedewa SA; Edge SB; Stewart AK; Halpern MT; Marlow NM; Ward EM
    J Health Care Poor Underserved; 2011 Feb; 22(1):128-41. PubMed ID: 21317511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
    Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):365-73. PubMed ID: 23275187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer and ethnicity: strong association between reproductive risk factors and estrogen receptor status in Asian patients - a retrospective study.
    Menes TS; Ozao J; Kim U
    Breast J; 2007; 13(4):352-8. PubMed ID: 17593039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.